Zavicefta 2g/0.5g powder for concentrate for solution for infusion

  • Name:

    Zavicefta 2g/0.5g powder for concentrate for solution for infusion

  • Company:
    info
  • Active Ingredients:

    Ceftazidime Pentahydrate, Avibactam sodium

  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)

Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 06/12/19

files-icon(Click to Download)
Summary of Product Characteristics last updated on medicines.ie: 12/4/2019
This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions.

Click on this link to Download PDF directly

Pfizer Healthcare Ireland

Pfizer Healthcare Ireland

Company Products

Medicine NameActive Ingredients
Medicine Name Genotropin Miniquick 1.8mg Active Ingredients Somatropin
Medicine Name Genotropin Miniquick 2.0mg Active Ingredients Somatropin
Medicine Name Gentamicin 40 mg/ml Injection, vials Active Ingredients Gentamicin sulfate
Medicine Name GEODON 20mg Capsules Active Ingredients ziprasidone hydrochloride monohydrate
Medicine Name Geodon 40 mg capsules Active Ingredients ziprasidone hydrochloride monohydrate
Medicine Name Geodon 80 mg capsules Active Ingredients ziprasidone hydrochloride monohydrate
Medicine Name Glyceryl Trinitrate 5 mg/ml Sterile Concentrate Active Ingredients Glyceryl Trinitrate
Medicine Name Halcion 125 micrograms Tablets Active Ingredients Triazolam
Medicine Name Halcion 250 microgram Tablets Active Ingredients Triazolam
Medicine Name Hypovase 0.5 mg Tablets Active Ingredients Prazosin hydrochloride
Medicine Name Hypovase 1mg Tablets Active Ingredients Prazosin hydrochloride
Medicine Name IBRANCE 75 mg 100mg & 125mg hard capsules Active Ingredients Palbociclib
Medicine Name Inflectra 100 mg powder for concentrate for solution for infusion Active Ingredients Infliximab
Medicine Name Inlyta 1mg, 3mg, 5mg & 7mg film-coated tablets Active Ingredients Axitinib
Medicine Name Inspra 25mg Film-Coated Tablets Active Ingredients Eplerenone
Medicine Name INSPRA 50 mg film-coated tablets. Active Ingredients Eplerenone
Medicine Name Istin 10mg Tablets Active Ingredients Amlodipine besilate
Medicine Name Istin 5mg Tablets Active Ingredients Amlodipine besilate
Medicine Name Ketalar 10mg/ml Injection/Infusion Active Ingredients Ketamine Hydrochloride
Medicine Name Ketalar 50mg/ml Solution for Injection/Infusion Active Ingredients Ketamine Hydrochloride
Medicine Name Lipitor 10 mg Chewable Tablets Active Ingredients Atorvastatin calcium trihydrate
Medicine Name Lipitor 10 mg film-coated tablets Active Ingredients Atorvastatin calcium trihydrate
Medicine Name Lipitor 20mg Chewable Tablets Active Ingredients Atorvastatin calcium trihydrate
Medicine Name Lipitor 20mg film-coated tablets Active Ingredients Atorvastatin calcium trihydrate
Medicine Name Lipitor 40mg film-coated tablets Active Ingredients Atorvastatin calcium trihydrate
101 - 125 of 227 items.Total: 10 pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 6 December 2019 PIL

Reasons for updating

  • Change to section 6 - date of revision

Updated on 15 April 2019 PIL

Reasons for updating

  • Change to section 6 - date of revision

Updated on 12 April 2019 SmPC

Reasons for updating

  • Change to section 10 - Date of revision of the text

Legal category: Product subject to medical prescription which may not be renewed (A)

Updated on 31 October 2018 PIL

Reasons for updating

  • Change to section 6 - date of revision

Updated on 31 October 2018 SmPC

Reasons for updating

  • Change to section 10 - Date of revision of the text

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

The SPC has been updated as follows:

Section 10: DATE OF REVISION OF THE TEXT has been updated – (10/2018)

Updated on 25 July 2018 PIL

Reasons for updating

  • Change to section 2 - excipient warnings
  • Improved presentation of PIL

Updated on 25 July 2018 SmPC

Reasons for updating

  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.4 - Special warnings and precautions for use

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

Sections 4.2 (Posology and method of administration) and 4.8 (Undesirable effects) updated following completion of the paediatric study C3591004.

Section 4.4 sodium statement updated to align with the Annex to the EU Commission guideline on ‘Excipients in the labelling and package leaflet of medicinal products for human use’.

Updated on 6 February 2018 SmPC

Reasons for updating

  • New SmPC for new product

Legal category: Product subject to medical prescription which may not be renewed (A)

Updated on 6 February 2018 SmPC

Reasons for updating

  • Change to section 7 - Marketing authorisation holder

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

The SPC has been updated as follows:
Section 7 - MA Holder address "Operations Services Group" corrected to "Operations Support Group".

Updated on 5 February 2018 PIL

Reasons for updating

  • New PIL for new product

Updated on 5 February 2018 PIL

Reasons for updating

  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - date of revision

Updated on 8 January 2018 PIL

Reasons for updating

  • New PIL for new product

Updated on 8 January 2018 SmPC

Reasons for updating

  • New SPC for new product

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

None provided